We have developed a unique portfolio of affinity resins to help you develop biosimilars, biobetters, and other types of recombinant proteins. These affinity resins can be used for clinical and commercial production.
CaptureSelect Affinity resin benefits:
- High Selectivity─high purity in a single capture step, independent of feedstock
- Mild elution conditions─retention of biological activity of target
- Reduction of process steps─helps reduce costs, allows higher yields
- Efficient clearance of impurities
In addition to affinity resins, we also offer product-specific ELISAs to measure any ligand potentially leaching from the column.
The graphic below depicts a typical workflow in which CaptureSelect resin can be used for a primary capture step for the efficient production of recombinant proteins.
CaptureSelect affinity matrices:
Product | Target applications | Uniqueness | RoboColumn™ format |
---|---|---|---|
CaptureSelect Follicle Stimulating Hormone (FSH) | Human follicle stimulating hormone | Binds only intact FSH due to alpha/beta chain epitope | |
CaptureSelect Human Albumin | Human serum albumin, albumin fusion proteins | Mild elution conditions help to protect fusion partner | X |
CaptureSelect hCG | Binds to the alpha chain of hCG (human chorionic gonadotropin) | Selective for hCG, with cross-binding to LH, FSH, and TSH | |
CaptureSelect hGH | Binds recombinant human Growth Hormone | High yield and retained activity | |
CaptureSelect tPA | Human tissue plasminogen activator (tPA) | The only tPA affinity resin available on the market | |
CaptureSelect TSH | Human Thyroid Stimulating Hormone | Selective for TSH with no cross binding to hormones of the Gonadotropin family | |
CaptureSelect C-tagXL | Binds the short C-tag sequence E-P-E-A (glutamic acid - proline - glutamic acid – alanine) when this affinity tag is fused at the C-terminus of a target protein | Optimized to obtain high yields in protein purification |
Quantitate the yield of your proteins during the production process with our analytical columns or develop your own analytical assay with CaptureSelect Ligand Conjugates.
When your specific process needs cannot be met with current products, our custom chromatography services are available to build you a unique solution. For more information, please visit Custom Capabilities .
CaptureSelect Leakage ELISAs
Products incorporating CaptureSelect technology are used for clinical and commercial manufacturing of a variety of biologicals. To support these products, Thermo Fisher Scientific has developed product-specific Leakage ELISAs that can be used for routine quality analysis. Below is a list of Leakage ELISAs and their corresponding affinity resins.
Product | Complementing resin |
---|---|
CaptureSelect FSH Ligand Leakage ELISA | CaptureSelect Follicle Stimulating Hormone (FSH) Affinity Matrix |
CaptureSelect HSA Ligand Leakage ELISA | CaptureSelect Human Albumin Affinity Matrix |
CaptureSelect hGH Ligand Leakage ELISA | CaptureSelect hGH Affinity Matrix |
CaptureSelect hCG Ligand Leakage ELISA | CaptureSelect hCG Affinity Matrix |
CaptureSelect tPA Ligand Leakage ELISA | CaptureSelect tPA Affinity Matrix |
CaptureSelect TSH Ligand Leakage ELISA | CaptureSelect TSH Affinity Matrix |
CaptureSelect C-tagXL Ligand Leakage ELISA | CaptureSelect C-tagXL Affinity Matrix |
CaptureSelect tPA Ligand Leakage ELISA | CaptureSelect tPA Affinity Matrix |
CaptureSelect VII Select Leakage ELISA Kit | VIISelect * |
CaptureSelect VIII Select Leakage ELISA Kit | VIIISelect * |
CaptureSelect IX Select Leakage ELISA Kit | IXSelect * |
CaptureSelect GCSFSelect Leakage ELISA Kit | GCSFSelect * |
CaptureSelect Alpha-1 Antitrypsin Select Leakage ELISA Kit | Alpha-1 Antitrypsin Select * |
* Complementing resins are available through GE Healthcare Life Sciences
Articles citing CaptureSelect technologies:
- Jing Jin (2018) Production, quality control, stability, and potency of cGMPproduced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells
- McCue JT, Selvitelli K, Walker J (2009) Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds. J Chromatogr A 1216(45):7824–7830.
- Casademunt E, Martinelle K, Jernberg M et al. (2012) The first recombinant human coagulation factor VIII of human origin. Eur J Haematol 89(2):165–176.
- Detmers F, Mueller F, Rohde J (2013) Increasing purity and yield in biosimilar production. BioProcess International, June 2013.
Contact us for more information about CaptureSelect technologies.
Bioprocessing resources
Access a targeted collection of scientific application notes, case studies, posters, white papers and more for bioprocessing:
Support
Events & Webinars
For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.